Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

New Biomarkers for Organ Viability Assessment During Hypothermic Machine Perfusion in Liver Transplantation: the Role of Extemporaneous Histological Examination.

NCT07674394 is registered in ClinicalTrials.gov with The Mediterranean Institute for Transplantation and Advanced Specialized Therapies as lead sponsor.

NCT NCT07674394
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07674394 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
New Biomarkers for Organ Viability Assessment During Hypothermic Machine Perfusion in Liver Transplantation: the Role of Extemporaneous Histological Examination.
Lead sponsor
The Mediterranean Institute for Transplantation and Advanced Specialized Therapies
Phase
Not applicable
Overall status
Not yet recruiting
Start date
July 31, 2026
Completion date
June 30, 2029
Enrollment
150 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

early allograft dysfunction, ischemia-reperfusion injury, liver transplantation (lt), primary non-function